Historically, in the first classification the term "Cardiomyopathy" [CMP] was used to describe a heart muscle disease of unknown cause, whereas heart muscle disorders of known etiology [such as coronary artery disease, valvular disease or hypertension] or those associated with systemic diseases were classified as specific CMP. With scientific progress [in particular in genetics and in biotechnology] it became more and more difficult to distinguish between CMP and specific heart muscle disease [primary and secondary CMP] as it was possible to understand the etiologic basis and pathophysiologic pathways of many so-called "idiopathic" heart muscle disorders. Therefore, in the last years important advances have been made to re-define and re-classify CMP.
DEFINITION, CLASSIFICATION, EPIDEMIOLOGY, AND CLINICAL RELEVANCE OF CARDIOMYOPATHIES.
Merlo, Marco;BUSSANI, ROSSANA;SINAGRA, GIANFRANCO;
2014-01-01
Abstract
Historically, in the first classification the term "Cardiomyopathy" [CMP] was used to describe a heart muscle disease of unknown cause, whereas heart muscle disorders of known etiology [such as coronary artery disease, valvular disease or hypertension] or those associated with systemic diseases were classified as specific CMP. With scientific progress [in particular in genetics and in biotechnology] it became more and more difficult to distinguish between CMP and specific heart muscle disease [primary and secondary CMP] as it was possible to understand the etiologic basis and pathophysiologic pathways of many so-called "idiopathic" heart muscle disorders. Therefore, in the last years important advances have been made to re-define and re-classify CMP.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
